Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?
TG Therapeutics (TGTX) saw its shares surge in the last session with trading volume being higher than average. The latest…
36,963€
5,40%
Echtzeit-Aktienkurs TG Therapeutics Inc.
Bid:
Ask:
Nachrichten zur TG Therapeutics Inc. Aktie
TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials
…
TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter
…
Why TG Therapeutics Stock Was Soaring This Week
Following news of an estimates-topping fourth quarter, TG Therapeutics (NASDAQ: TGTX) stock was a hot item with investors over the…
TG Therapeutics soared 17% after earnings surprise
Here’s what happened to TG Therapeutics.…
TG Therapeutics stock rises following upbeat Q4 earnings By Investing.com
TG Therapeutics stock rises following upbeat Q4 earnings…
TG Therapeutics: Entering 2025 With Increased Investor Expectations
…
TG Therapeutics: 2025 Revenues Will Smash Expectations
…
TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?
TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions…
TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst
…
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Presentation scheduled for Monday, January 13, 2025, at 4:30 PM PT Presentation scheduled for Monday, January 13, 2025, at 4:30…
TG Therapeutics to Participate in the Evercore HealthCONx Conference
Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ET Fireside chat scheduled for Tuesday, December 3, 2024,…
TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript
…
TD Cowen sieht 102 % Kurspotenzial für TG Therapeutics Inc. (TGTX)
TG Therapeutics Inc. (TGTX) ist ein biopharmazeutisches Unternehmen, das sich auf innovative Therapien zur Behandlung von Autoimmun- und Krebserkrankungen spezialisiert…
TG Therapeutics: Die Briumvi Wachstumsstory bleibt durch neue Daten intakt
TG Therapeutics beschäftigt sich mit dem Erwerb, der Entwicklung und Vermarktung neuartiger Behandlungen für B-Zell-Malignome und Autoimmunerkrankungen. Das Unternehmen…
TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval
…
Stocks Strengthen; These IPOs Stand Out
TG Therapeutics cruised past a 23.12 alternative entry.…
TG Therapeutics: Pressure On Briumvi To Perform As Share Price Hits Resistance
…
June 2024 New Analysts Cover Uber, TG Therapeutics, CarMax, And More
…
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
Fireside chat scheduled for Wednesday, June 5, 2024, at 1:30 PM ET Fireside chat scheduled for Wednesday, June 5, 2024,…
TG Therapeutics: Less Room For Doubt About Briumvi
…
Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi By Investing.com
Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi…
TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript
…
G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript
…
TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
Conference call to be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET Conference call to be held tomorrow,…
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of…
G1 Therapeutics, Inc. (GTHX) Q4 2023 Earnings Call Transcript
…
TG Therapeutics, Inc. (TGTX) Q4 2023 Earnings Call Transcript
…